Intravenous midazolam infusion for sedation of infants in the neonatal intensive care unit

Comparison of pain during heel prick in preterm neonates receiving only expressed breast milk and expressed breast milk with kangaroo mother care

“…The (Table 2 13 There are 2 approaches for the management of pain in neonates; they are categorized as pharmacological (morphine, paracetamol, and fentanyl). [14][15][16][17] and non-pharmacological measures (breastfeeding, nonnutritive sucking, swaddling, kangaroo mother care, massage, music, and sweet tasting solutions like sucrose or glucose. 18 Exclusive breastfeeding and Kangaroo mother care are part of essential newborn care.…”

Comparison of pain during heel prick in preterm neonates receiving only expressed breast milk and expressed breast milk with kangaroo mother care

“…The (Table 2 13 There are 2 approaches for the management of pain in neonates; they are categorized as pharmacological (morphine, paracetamol, and fentanyl). [14][15][16][17] and non-pharmacological measures (breastfeeding, nonnutritive sucking, swaddling, kangaroo mother care, massage, music, and sweet tasting solutions like sucrose or glucose. 18 Exclusive breastfeeding and Kangaroo mother care are part of essential newborn care.…”

Clinical Pharmacology of Midazolam in Neonates and Children: Effect of Disease—A Review

“…Ng et al [ 21 ] recently reviewed the effects of midazolam administered intravenously to infants aged 28 days or less for sedation. These authors reached the conclusion that there are no sufficient data to administrate midazolam intravenously for sedation to neonates undergoing intensive care.…”

Developing a model of neonatal nurse‐controlled analgesia: A Delphi study

“…The inclusion of sedatives in a model of analgesia was queried by several expert panel members throughout the three rounds. Midazolam, a benzodiazepine, is commonly used in conjunction with an opioid in the management of acute and chronic pain to manage agitation (Ng et al., 2017). Midazolam has also been associated with adverse neurological outcomes and concerns have been raised about its safety and efficacy in the neonatal population (Ng et al., 2017; Valentine & Kummick, 2022).…”

“…Midazolam, a benzodiazepine, is commonly used in conjunction with an opioid in the management of acute and chronic pain to manage agitation (Ng et al., 2017). Midazolam has also been associated with adverse neurological outcomes and concerns have been raised about its safety and efficacy in the neonatal population (Ng et al., 2017; Valentine & Kummick, 2022). Furthermore, midazolam has no analgesic relieving properties and its use may result in over‐sedation and an inability to accurately assess pain (Valentine & Kummick, 2022).…”

Comparison of pain during heel prick in preterm neonates receiving only expressed breast milk and expressed breast milk with kangaroo mother care

“…The (Table 2 13 There are 2 approaches for the management of pain in neonates; they are categorized as pharmacological (morphine, paracetamol, and fentanyl). [14][15][16][17] and non-pharmacological measures (breastfeeding, nonnutritive sucking, swaddling, kangaroo mother care, massage, music, and sweet tasting solutions like sucrose or glucose. 18 Exclusive breastfeeding and Kangaroo mother care are part of essential newborn care.…”

Clinical Pharmacology of Midazolam in Neonates and Children: Effect of Disease—A Review

“…Ng et al [ 21 ] recently reviewed the effects of midazolam administered intravenously to infants aged 28 days or less for sedation. These authors reached the conclusion that there are no sufficient data to administrate midazolam intravenously for sedation to neonates undergoing intensive care.…”

Developing a model of neonatal nurse‐controlled analgesia: A Delphi study

“…The inclusion of sedatives in a model of analgesia was queried by several expert panel members throughout the three rounds. Midazolam, a benzodiazepine, is commonly used in conjunction with an opioid in the management of acute and chronic pain to manage agitation (Ng et al., 2017). Midazolam has also been associated with adverse neurological outcomes and concerns have been raised about its safety and efficacy in the neonatal population (Ng et al., 2017; Valentine & Kummick, 2022).…”

“…Midazolam, a benzodiazepine, is commonly used in conjunction with an opioid in the management of acute and chronic pain to manage agitation (Ng et al., 2017). Midazolam has also been associated with adverse neurological outcomes and concerns have been raised about its safety and efficacy in the neonatal population (Ng et al., 2017; Valentine & Kummick, 2022). Furthermore, midazolam has no analgesic relieving properties and its use may result in over‐sedation and an inability to accurately assess pain (Valentine & Kummick, 2022).…”

Comparison of pain during heel prick in preterm neonates receiving only expressed breast milk and expressed breast milk with kangaroo mother care

“…The (Table 2 13 There are 2 approaches for the management of pain in neonates; they are categorized as pharmacological (morphine, paracetamol, and fentanyl). [14][15][16][17] and non-pharmacological measures (breastfeeding, nonnutritive sucking, swaddling, kangaroo mother care, massage, music, and sweet tasting solutions like sucrose or glucose. 18 Exclusive breastfeeding and Kangaroo mother care are part of essential newborn care.…”

Clinical Pharmacology of Midazolam in Neonates and Children: Effect of Disease—A Review

“…Ng et al [ 21 ] recently reviewed the effects of midazolam administered intravenously to infants aged 28 days or less for sedation. These authors reached the conclusion that there are no sufficient data to administrate midazolam intravenously for sedation to neonates undergoing intensive care.…”

Developing a model of neonatal nurse‐controlled analgesia: A Delphi study

“…The inclusion of sedatives in a model of analgesia was queried by several expert panel members throughout the three rounds. Midazolam, a benzodiazepine, is commonly used in conjunction with an opioid in the management of acute and chronic pain to manage agitation (Ng et al., 2017). Midazolam has also been associated with adverse neurological outcomes and concerns have been raised about its safety and efficacy in the neonatal population (Ng et al., 2017; Valentine & Kummick, 2022).…”

“…Midazolam, a benzodiazepine, is commonly used in conjunction with an opioid in the management of acute and chronic pain to manage agitation (Ng et al., 2017). Midazolam has also been associated with adverse neurological outcomes and concerns have been raised about its safety and efficacy in the neonatal population (Ng et al., 2017; Valentine & Kummick, 2022). Furthermore, midazolam has no analgesic relieving properties and its use may result in over‐sedation and an inability to accurately assess pain (Valentine & Kummick, 2022).…”